Wiener klinische Wochenschrift

, Volume 129, Issue 15–16, pp 579–582 | Cite as

Neurotoxicity of cyclosporine A in children with steroid-resistant nephrotic syndrome: is cytotoxic edema really an unfavorable predictor of permanent neurological damage?

  • Danica Batinić
  • Danko Milošević
  • Boris Filipović-Grčić
  • Marija Topalović-Grković
  • Nina Barišić
  • Daniel Turudić
short report

Summary

Background

Cyclosporine A-associated neurotoxicity has been reported mainly after organ transplantation. Only a small number of children with steroid-resistant nephrotic syndrome and cyclosporine A-associated neurotoxicity have been reported.

Patients

We report three children, aged 4, 11, and 15, with steroid-resistant nephrotic syndrome and cyclosporine A-associated neurotoxicity. In two of the patients, primary diagnosis was idiopathic nephrotic syndrome, and in one it was IgA nephropathy. Magnetic resonance with diffusion-weighted imaging, combined with quantification of apparent diffusion coefficient values, showed lesions caused by cytotoxic edema indicating irreversible brain damage. Nonetheless, the patients fully recovered clinically and radiologically after prompt discontinuation of cyclosporine A.

Conclusions

Neurotoxic effects should be suspected in any child with nephrotic syndrome treated with cyclosporine A in whom sudden neurological symptoms occur. Cytotoxic edema is a rare finding in pediatric patients. However, even in such cases with seemingly irreversible brain damage, full recovery without permanent neurological sequels is possible with prompt cyclosporine A discontinuation and supportive therapy.

Keywords

Cyclosporine A neurotoxicity Steroid-resistant nephrotic syndrome Children 

References

  1. 1.
    Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol. 1999;246:339–46.CrossRefPubMedGoogle Scholar
  2. 2.
    Lombel RM, Hodson EM, Gipson DS. Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol. 2013;28:409–14.CrossRefPubMedGoogle Scholar
  3. 3.
    Jeong MH, Lee JH, Yum MS, Ko TS, Park SY. A case of posterior reversible encephalopathy syndrome during cyclosporine therapy in a child with steroid resistant nephrotic syndrome. J Korean Soc Pediatr Nephrol. 2007;11:92–9.CrossRefGoogle Scholar
  4. 4.
    Saeed B, Abou-Zor N, Amer Z, Kanani I, Hilal M. Cyclosporin-A induced posterior revesible encephalopathy syndrome. Saudi J Kidney Dis Transpl. 2008;19:439–42.PubMedGoogle Scholar
  5. 5.
    Sakai N, Kawasaki Y, Imaizumi T, Kanno S, et al. Two patients with focal segmental glomerulosclerosis complicated by cyclosporine-induced reversible posterior leukoencephalopathy syndrome. Clin Nephrol. 2010;73:482–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Taque S, Peudenier S, Gie S, et al. Central neurotoxicity of cyclosporine in two children with nephrotic syndrome. Pediatr Nephrol. 2004;19:276–80.CrossRefPubMedGoogle Scholar
  7. 7.
    Zhang Y, Zhou J, Chen Y. Posterior reversible encephalopathy syndrome in a child with steroid-resistant nephrotic syndrome: a case report and review of literature. Int J Clin Exp Pathol. 2014;7:4433–7.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Ishikura K, Hamasaki Y, Skai T, Hataya H, Mak RH, Honda M. Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol. 2012;27:375–84.CrossRefPubMedGoogle Scholar
  9. 9.
    Iyer RS, Chaturvedi A, Pruthi S, Khanna PC, Ishak GE. Medication neurotoxicity in children. Pediatr Radiol. 2011;41:1455–64.CrossRefPubMedGoogle Scholar
  10. 10.
    Ishikura K, Hamasaki Y, Sakai T, et al. Children with posterior reversible encephalopathy syndrome associated with atypical diffusion-weighted imaging and apparent diffusion coefficient. Clin Exp Nephrol. 2011;15:275–80.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2017

Authors and Affiliations

  • Danica Batinić
    • 1
  • Danko Milošević
    • 1
  • Boris Filipović-Grčić
    • 1
  • Marija Topalović-Grković
    • 2
  • Nina Barišić
    • 1
  • Daniel Turudić
    • 3
  1. 1.University Zagreb School of Medicine, Department of PediatricsUniversity Hospital Center ZagrebZagrebCroatia
  2. 2.University Zagreb School of Medicine, Department of Anesthesiology and Intensive CareUniversity Hospital Center ZagrebZagrebCroatia
  3. 3.School of MedicineUniversity of ZagrebZagrebCroatia

Personalised recommendations